ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2025
[Expert Consensus on the Clinical Application of Sodium Cantharidinate and Vitamin B6 Injection].
Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer prevention and control in China face severe challenges. Although targeted therapy and immunotherapy have made remarkable progress, chemotherapy remains a cornerstone of comprehensive cancer treatment, and its toxic side effects pose a significant challenge in clinical practice. As a compound formulation exhibiting both antitumor and toxicity-reducing effects, Sodium cantharidinate and vitamin B6 injection has been utilized in clinical practice in China for over two decades. However, standardized guidelines for its application remain lacking in routine clinical use. To address this gap, the Lung Cancer Specialty Committee of Chinese Elderly Health Care Association organized a panel of experts to develop this consensus document, drawing on current evidence-based data and accumulated clinical experience. This consensus provides a systematic elaboration of the preparation's pharmacological mechanisms and pharmacokinetic profiles, and offers specific recommendations for its clinical application across various malignancies, including lung cancer and hepatocellular carcinoma. The primary objective of this consensus is to establish standardized guidance for clinicians regarding the appropriate use of Sodium cantharidinate and vitamin B6 injection, thereby promoting its rational application and ultimately enhancing treatment efficacy and quality of life for cancer patients. .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.